19015-Lymphomas-NA-596

Lymphomas

A Phase Ib, open-label, randomized study to assess safety and preliminary efficacy of Tafasitamab in addition to R-CHOP or Tafasitamab plus Lenalidomide in addition to R-CHOP in patients with newly diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) � First-MIND (MOR208C107)

  • Details

ClinicalTrials.gov ID: NCT04134936
Diagnosis Type: NA
USOR Number:

  • Address

210 SE 136th Ave
Vancouver, WA 98684
P: (360) 944-9889

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.